It points that the possible negative effects of the vaccine is that the H1N1 version of the swine flu is not very lethal in comparison with other variants of the flu. Some experts have said that some people have allergic reactions to the shot's component ingredients. However, studies have ...
We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some...
While some of that is earmarked for economic and humanitarian assistance for Ukraine, most of it will go into the coffers of the weapons industry — including Raytheon, on whose Board of Directors the current Secretary of Defense, Lloyd Austin, sat immediately before being chosen by Biden to r...
If an initial COVID-19 vaccine is about as effective as a flu shot, uptake by the American public may fall far short of the 70% level needed to achieve herd immunity, new Cornell research suggests. In surveys of nearly 2,000 American adults, barely half said they would be willing to t...
Under-Pressure Moderna Banks $590m To Speed Up Bird Flu Vaccine 20 Jan 2025 • By Kevin Grogan A week after a downbeat forecast at J.P. Morgan Healthcare Conference, the US mRNA specialist has pocketed another sizeable sum from the US Department of Health and Human Services to accelerate...
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. Owing to this increased risk, patients with cancer have been prioritized for COVID-19 vaccination globally, for both pr
"Developing vaccines against respiratory virus is incredibly difficult. If you think about the flu vaccine that we use every year, it's only about 40% to 60% effective," Dr. Carlos del Rio of Emory University said Tuesday on CNBC's "Squawk Box." The Food and Drug Administration indicated...
Most recently, the Flu Watch Cohort Study10has investigated whether pre-existing T-cell responses targeting internal viral proteins could provide protective immunity against pandemic and seasonal influenza. NP is one of the most conserved internal influenza antigens; even the most divergent protein seque...
Prevention of infection through public vaccination would be the only efficient strategy to control the morbidity and mortality caused by COVID-19. To date, several COVID-19 vaccines using different platforms including nucleic acid-based vaccines, adenovirus-based vaccines, protein-based vaccines, and ...
The company behind China’s first homegrown mRNA Covid-19 vaccine aims to have efficacy data from late-stage testing of the shot before the end of the year, a key step in the nation’s drive to match western use of the cutting-edge technology. ...